Figure 5From: Intermedin in rat uterus: changes in gene expression and peptide levels across the estrous cycle and its effects on uterine contractionRepresentative tracings of rat uterine muscular contraction in vitro.Treatment of IMD alone (A), and together with receptor blockers hADM22-52 (B), hCGRP8-37 (C), or hIMD17-47 (D), or enzyme inhibitors of PKA (KT5720) (E), NO synthase (L-NAME) (F), or PI3K (Wortmannin)(G).Back to article page